Skip to content

Effect of milrinone on controlled low central venous pressure and the postoperative quality of recovery during laparoscopic hepatectomy

Impact of permissive hypercapnia on regional cerebral oxygen saturation in patients undergoing laparoscopic hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056891
Enrollment
Unknown
Registered
2022-02-22
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic diseases

Interventions

control group:Nitroglycerin is continuously pumped during operation

Sponsors

Jinhua Hospital Affiliated to Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. For patients undergoing elective laparoscopic hepatectomy under controlled low central venous pressure, the operation time is expected to be more than 2 hours. 2. Aged 18 to 70 years. 3. The ASA classification is I-II.

Exclusion criteria

Exclusion criteria: 1. Obesity (BMI > 32kg/m^2); 2. History of cerebrovascular diseases and neuropsychiatric diseases; 3. Patients with poorly controlled hypertension and postural hypotension; 4. Severe cardiovascular diseases (such as hypertrophic cardiomyopathy, myocardial infarction, heart function III-IV, LEVF< 50%, moderate to severe heart valve regurgitation, severe arrhythmia); 5. Dyspnea and respiratory failure; 6. Liver and kidney dysfunction; 7. Have used heparin antithrombin or warfarin anticoagulation factor or aspirin antiplatelet aggregation or other anticoagulant drugs recently (within 2 weeks); 8. Allergic history and contraindications to any drug used.

Design outcomes

Primary

MeasureTime frame
Intraoperative blood loss;Allogeneic blood transfusion;Grade of surgical field;

Secondary

MeasureTime frame
The intraoperative hemodynamics signs;Quality of postoperative recovery;Liver function;Renal function;

Countries

China

Contacts

Public ContactLyu Huayan
flymouse001@163.com+86 13967446757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026